Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Mesothelioma, Malignant 2Colonic Neoplasms 2Breast Neoplasms 2Small Cell Lung Carcinoma 1Sezary Syndrome 1Sarcoma, Synovial 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Rectal Neoplasms 1Pancreatic Neoplasms 1Osteosarcoma 1Neuroblastoma 1Neoplasms 1Neoplasm Metastasis 1Mycosis Fungoides 1Melanoma 1Lung Neoplasms 1Liposarcoma, Myxoid 1Kidney Neoplasms 1Infections 1Colorectal Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1

Interventions

plerixafor 2Voriconazole 2Levofloxacin 2threonic acid 1amphotericin B, deoxycholate drug combination 1Polymerase Chain Reaction 1Nystatin 1Magnesium Sulfate 1Interferon-gamma 1Immunoenzyme Techniques 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1ER 30346 1Cone-Beam Computed Tomography 1Cefepime 1Caspofungin 1Bronchoscopy 1Bronchoalveolar Lavage 1Bevacizumab 1Anidulafungin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Infections × Interferon-gamma × Clear all
NCT00059878 2013-06-19

Voriconazole With or Without Interferon Gamma in Treating Patients With Aspergillosis or Other Fungal Infections

National Cancer Institute (NCI)

Phase 2 Completed

Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡